Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Mar 8:380:e072924.
doi: 10.1136/bmj-2022-072924.

Ionising radiation and cardiovascular disease: systematic review and meta-analysis

Affiliations
Meta-Analysis

Ionising radiation and cardiovascular disease: systematic review and meta-analysis

Mark P Little et al. BMJ. .

Abstract

Objective: To systematically review and perform a meta-analysis of radiation associated risks of cardiovascular disease in all groups exposed to radiation with individual radiation dose estimates.

Design: Systematic review and meta-analysis.

Main outcome measures: Excess relative risk per unit dose (Gy), estimated by restricted maximum likelihood methods.

Data sources: PubMed and Medline, Embase, Scopus, Web of Science Core collection databases.

Eligibility criteria for selecting studies: Databases were searched on 6 October 2022, with no limits on date of publication or language. Animal studies and studies without an abstract were excluded.

Results: The meta-analysis yielded 93 relevant studies. Relative risk per Gy increased for all cardiovascular disease (excess relative risk per Gy of 0.11 (95% confidence interval 0.08 to 0.14)) and for the four major subtypes of cardiovascular disease (ischaemic heart disease, other heart disease, cerebrovascular disease, all other cardiovascular disease). However, interstudy heterogeneity was noted (P<0.05 for all endpoints except for other heart disease), possibly resulting from interstudy variation in unmeasured confounders or effect modifiers, which is markedly reduced if attention is restricted to higher quality studies or those at moderate doses (<0.5 Gy) or low dose rates (<5 mGy/h). For ischaemic heart disease and all cardiovascular disease, risks were larger per unit dose for lower dose (inverse dose effect) and for fractionated exposures (inverse dose fractionation effect). Population based excess absolute risks are estimated for a number of national populations (Canada, England and Wales, France, Germany, Japan, USA) and range from 2.33% per Gy (95% confidence interval 1.69% to 2.98%) for England and Wales to 3.66% per Gy (2.65% to 4.68%) for Germany, largely reflecting the underlying rates of cardiovascular disease mortality in these populations. Estimated risk of mortality from cardiovascular disease are generally dominated by cerebrovascular disease (around 0.94-1.26% per Gy), with the next largest contribution from ischaemic heart disease (around 0.30-1.20% per Gy).

Conclusions: Results provide evidence supporting a causal association between radiation exposure and cardiovascular disease at high dose, and to a lesser extent at low dose, with some indications of differences in risk between acute and chronic exposures, which require further investigation. The observed heterogeneity complicates a causal interpretation of these findings, although this heterogeneity is much reduced if only higher quality studies or those at moderate doses or low dose rates are considered. Studies are needed to assess in more detail modifications of radiation effect by lifestyle and medical risk factors.

Systematic review registration: PROSPERO CRD42020202036.

PubMed Disclaimer

Conflict of interest statement

Competing interest: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: AJE has received speaker fees from Ionetix; has received consulting fees from WL Gore & Associates; has received authorship fees from Wolters Kluwer Healthcare–UpToDate; and has received grants to his institution from Attralus, Canon Medical Systems, Eidos Therapeutics, GE Healthcare, Pfizer, Roche Medical Systems, WL Gore & Associates, and XyloCor Therapeutics; none of these are related to the present work. Otherwise no other authors declare any competing interests.

Figures

Fig 1
Fig 1
PRISMA flow diagram showing exclusions made to derive the final set of studies used
Fig 2
Fig 2
Funnel plot of risks by four major cardiovascular disease endpoints. A study without appreciable selection bias should have a more or less balanced funnel plot, with points spread more or less equally to left and right of the vertical axis of the funnel

Comment in

References

    1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128. 10.1016/S0140-6736(12)61728-0 - DOI - PMC - PubMed
    1. World Health Organization (WHO). World Health Organization Statistical Information System (WHOSIS). Updated 17 November 2015. https://www.who.int/gho/en/. 2015.
    1. Centers for Disease Control and Prevention (CDC). CDC Wonder Atlanta, GA: Centers for Disease Control; 2020. https://wonder.cdc.gov/.
    1. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. 10.1161/01.CIR.97.18.1837 - DOI - PubMed
    1. Dhingra R, Vasan RS. Age as a risk factor. Med Clin North Am 2012;96:87-91. 10.1016/j.mcna.2011.11.003 - DOI - PMC - PubMed

Publication types